Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 May;59(5):401–407. doi: 10.1136/thx.2003.011197

Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries

R Bennett 1, R Jones 1, A Morice 1, C Smith 1, M Cowen 1
PMCID: PMC1747004  PMID: 15115867

Abstract

Background: Urotensin II (UII) has been identified as a ligand for the orphan receptor GPR14 through which it elicits potent vasoconstriction in humans and non-human primates. The pulmonary vasculature is particularly sensitive; human UII (hUII) exhibits a potency 28 times that of endothelin (ET)-1 in isolated pulmonary arteries obtained from cynomolgus monkeys. However, hUII induced vasoconstriction in isolated human intralobar pulmonary arteries is variable, possibly as a result of location dependent differences in receptor density or because it is only uncovered by disease dependent endothelial dysfunction.

Methods: The vasoactivity of both hUII and gobi UII (gUII) in comparison with ET-1 and ET-3 was studied in isolated perfused lung preparations (n = 14) and isolated intralobar pulmonary arteries (n = 40, mean diameter 548 (27) µm) obtained from 17 men of mean (SE) age 67 (2) years and eight women of mean (SE) age 65 (3) years with a variety of vascular diseases.

Results: ET-1 (10 pM–100 nM) and ET-3 (10 pM–30 nM) elicited vasoconstriction in the lung preparations, inducing comparable increases in pulmonary arterial pressure of 24.8 (4.5) mm Hg and 14.5 (4.9) mm Hg, respectively, at 30 nM (p = 0.13). Similarly, ET-1 (10 pM–300 nM) and ET-3 (10 pM–100 nM) caused marked vasoconstriction in isolated pulmonary arteries, inducing maximal changes in tension of 4.36 (0.26) mN/mm and 1.54 (0.44) mN/mm, respectively, generating –logEC50 values of 7.67 (0.04) M and 8.08 (0.07) M, respectively (both p<0.05). However, neither hUII nor gUII (both 10 pM–1 µM) had any vasoactive effect in either preparation.

Conclusion: UII does not induce vasoconstriction in isolated human pulmonary arterial or lung preparations and is therefore unlikely to be involved in the control of pulmonary vascular tone.

Full Text

The Full Text of this article is available as a PDF (233.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames R. S., Sarau H. M., Chambers J. K., Willette R. N., Aiyar N. V., Romanic A. M., Louden C. S., Foley J. J., Sauermelch C. F., Coatney R. W. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 1999 Sep 16;401(6750):282–286. doi: 10.1038/45809. [DOI] [PubMed] [Google Scholar]
  2. Behm David J., Harrison Stephen M., Ao Zhaohui, Maniscalco Kristeen, Pickering Susan J., Grau Evelyn V., Woods Tina N., Coatney Robert W., Doe Christopher P. A., Willette Robert N. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice. Br J Pharmacol. 2003 May;139(2):464–472. doi: 10.1038/sj.bjp.0705254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bottrill F. E., Douglas S. A., Hiley C. R., White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol. 2000 Aug;130(8):1865–1870. doi: 10.1038/sj.bjp.0703513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Böhm Felix, Pernow John. Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol. 2002 Jan;135(1):25–27. doi: 10.1038/sj.bjp.0704448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J. C., Conlon J. M., Bern H. A., Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15803–15808. doi: 10.1073/pnas.95.26.15803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas S. A., Sulpizio A. C., Piercy V., Sarau H. M., Ames R. S., Aiyar N. V., Ohlstein E. H., Willette R. N. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol. 2000 Dec;131(7):1262–1274. doi: 10.1038/sj.bjp.0703690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol. 1987 May;91(1):205–212. doi: 10.1111/j.1476-5381.1987.tb09000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gibson A., Conyers S., Bern H. A. The influence of urotensin II on calcium flux in rat aorta. J Pharm Pharmacol. 1988 Dec;40(12):893–895. doi: 10.1111/j.2042-7158.1988.tb06298.x. [DOI] [PubMed] [Google Scholar]
  9. Hillier C., Berry C., Petrie M. C., O'Dwyer P. J., Hamilton C., Brown A., McMurray J. Effects of urotensin II in human arteries and veins of varying caliber. Circulation. 2001 Mar 13;103(10):1378–1381. doi: 10.1161/01.cir.103.10.1378. [DOI] [PubMed] [Google Scholar]
  10. Itoh H., Itoh Y., Rivier J., Lederis K. Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am J Physiol. 1987 Feb;252(2 Pt 2):R361–R366. doi: 10.1152/ajpregu.1987.252.2.R361. [DOI] [PubMed] [Google Scholar]
  11. Itoh H., McMaster D., Lederis K. Functional receptors for fish neuropeptide urotensin II in major rat arteries. Eur J Pharmacol. 1988 Apr 27;149(1-2):61–66. doi: 10.1016/0014-2999(88)90042-8. [DOI] [PubMed] [Google Scholar]
  12. Jones R. D., Wanstall J. C., Gambino A., Morice A. H. The effect of the endothelin ET(A) receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction. Eur J Pharmacol. 1999 Jun 25;374(3):367–375. doi: 10.1016/s0014-2999(99)00300-3. [DOI] [PubMed] [Google Scholar]
  13. Liu Q., Pong S. S., Zeng Z., Zhang Q., Howard A. D., Williams D. L., Jr, Davidoff M., Wang R., Austin C. P., McDonald T. P. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun. 1999 Dec 9;266(1):174–178. doi: 10.1006/bbrc.1999.1796. [DOI] [PubMed] [Google Scholar]
  14. MacLean M. R., Alexander D., Stirrat A., Gallagher M., Douglas S. A., Ohlstein E. H., Morecroft I., Polland K. Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br J Pharmacol. 2000 May;130(2):201–204. doi: 10.1038/sj.bjp.0703314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maguire J. J., Kuc R. E., Davenport A. P. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol. 2000 Oct;131(3):441–446. doi: 10.1038/sj.bjp.0703601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pearson D., Shively J. E., Clark B. R., Geschwind I. I., Barkley M., Nishioka R. S., Bern H. A. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A. 1980 Aug;77(8):5021–5024. doi: 10.1073/pnas.77.8.5021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rogers T. K., Stewart A. G., Morice A. H. Effect of chronic hypoxia on rat pulmonary resistance vessels: vasodilatation by atrial natriuretic peptide. Clin Sci (Lond) 1992 Dec;83(6):723–729. doi: 10.1042/cs0830723. [DOI] [PubMed] [Google Scholar]
  18. Rossowski Wojciech J., Cheng Beng-L, Taylor John E., Datta Rakesh, Coy David H. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol. 2002 Mar 8;438(3):159–170. doi: 10.1016/s0014-2999(02)01341-9. [DOI] [PubMed] [Google Scholar]
  19. Saetrum Opgaard O., Nothacker H., Ehlert F. J., Krause D. N. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol. 2000 Oct 13;406(2):265–271. doi: 10.1016/s0014-2999(00)00672-5. [DOI] [PubMed] [Google Scholar]
  20. Sauzeau V., Le Mellionnec E., Bertoglio J., Scalbert E., Pacaud P., Loirand G. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res. 2001 Jun 8;88(11):1102–1104. doi: 10.1161/hh1101.092034. [DOI] [PubMed] [Google Scholar]
  21. Stirrat A., Gallagher M., Douglas S. A., Ohlstein E. H., Berry C., Kirk A., Richardson M., MacLean M. R. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H925–H928. doi: 10.1152/ajpheart.2001.280.2.H925. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES